Asta Medica/Ares-Serono To File Cetrotide NDA By End Of 1999
Executive Summary
Asta Medica and Ares-Serono intend to file an NDA by the end of the year for the luteinising hormone-releasing hormone antagonist Cetrotide (cetrorelix) in fertility treatment.
You may also be interested in...
EMEA Clears Four Biologics In 1999 Before FDA, And Five Later Than FDA
The European Medicines Evaluation Agency approved four biological products in 1999 that have not yet been licensed by FDA.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011